Application Information

This drug has been submitted to the FDA under the reference 088607/001.

Names and composition

"GYNE-SULF" is the commercial name of a drug composed of TRIPLE SULFA (SULFABENZAMIDE and SULFACETAMIDE and SULFATHIAZOLE).

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
088607/001 GYNE-SULF TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
005794/001 SULTRIN TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
005794/002 SULTRIN TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) TABLET/VAGINAL 184MG and 143.75MG and 172.5MG
086424/001 TRIPLE SULFA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
087285/001 TRIPLE SULFA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
087864/001 TRIPLE SULFA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
087887/001 TRYSUL TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
088462/001 TRIPLE SULFA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) TABLET/VAGINAL 184MG and 143.75MG and 172.5MG
088463/001 TRIPLE SULFA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) TABLET/VAGINAL 184MG and 143.75MG and 172.5MG
088607/001 GYNE-SULF TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%
088821/001 VAGILIA TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE) CREAM/VAGINAL 3.7% and 2.86% and 3.42%

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved